Nt-Probnp Rapid Test Kits/Cardiac Biomarker /Hf with Ce

Product Name: Nt-Probnp Rapid Test Kits/Cardiac Biomarker /Hf with Ce Model NO.: CG1002 Group: All Men Certification: CE, ISO13485 Type: Poct Classification: Biological Diagnostics Suitable Machine: Fia8000/ Fia8600 Trademark: GP Transport Package: Carton Specification: 25 test /BOX Origin: Jiangsu HS Code: 3002190090 Product Description The One Step Test for NT-proBNP (colloidal gold) is intended for use together with the FIA8000 Quantitative Immunoassay Analyzer (FIA8000). The product employs colloidal gold immunochromatogrphy to determine NT-proBNP in human serum, plasma, or whole blood specimens. One monoclonal antibody and one polyclonal antibody are employed to identify NT-proBNP specifically, resulting in apurplish red streak appears on the test line. The color intensity of the test line increases in proportion to the concentrations of NT-proBNP.Then insert test card into the FIA8000 Quantitative Immunoassay Analyzer, the concentration of NT-proBNP is measured quantitatively and displayed on the screen. The result can be transmitted to the lab or hospital information system.PackageA box package contains 25 tests:Foil bag, which contains one test card and one desiccant25Disposable pipet25Manual1SD card1Whole blood buffer11. Early detection for patients with heart failure;2. Diagnosis and risk stratification of heart failure;3. Distinguishing dyspnea caused by heart failure from other diseases;4. Monitoring and prognostic assessment of heart failure treatment;5. Screening and diagnosis for non-cardiac heart failure patients;6. As an aid in the risk stratification for ACS.Any questions or interests, please contact us.Website:http://www.bio-gp.com.cn/Add:No.9 Bofu Road,Luhe Distric, Nanjing,211505,ChinaPostal:211505Company ProfileGetein Biotech Inc. (stock code: 603387), established in 2002, is afully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes abroad range of innovative diagnostic test kits in point-of-care, clinical chemistry, chemiluminescent assays, and molecular diagnostics. The company sits on a10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. It also manufactures analytic medical devices and avariety of biological and non-biological raw materials for applications in diagnostics, pharmaceuticals, and academic research.